If you need more lookups,
subscriptions start at $34 USD/month.
Silvia Comis Work
Head of Clinical Development and Regulatory Affairs @ (December 2021 - Present)
Senior Medical Director, Oncology - Therapeutic Science and Strategy Unit @ (March 2018 - December 2021)
European Head of Early Products Medical Affairs @ (June 2017 - March 2018)
European Clinical Development Head @ (May 2015 - May 2017)
Medical Director a.i., Oncology BU, Novartis Poland and European Medical Aff. Director New Products @ (March 2015 - May 2015)
European Medical Affairs Director New Products @ (February 2013 - May 2015)
European Medical Affairs Director Rare Tumors @ (December 2010 - January 2013)
Head of Clinical Development and Regulatory Affairs @ (January 2005 - December 2010)
Head of Clinical Development Europe, Novuspharma @ (January 2002 - January 2005)
Oncology, Therapeutic Area Leader, Medical Affairs, Aventis RPR @ (January 1995 - January 2002)
Internal Medicine and Nephrology Project Physician, Synthelabo @ (January 1992 - January 1995)
Oncology, Senior Scientific Manager @ (January 1989 - January 1992)
Silvia Comis Education
Università degli Studi di Pavia
Board Certified (Pharmacology)
Università degli Studi di Pavia
MD (Medicine)
Università degli Studi di Pavia
Board Certified (Endocrinology)
Silvia Comis Skills
Clinical Research
Medicine
CTMS
Clinical Trials
Oncology
Pharmaceutical Industry
GCP
Drug Development
Clinical Development
Nephrology
Biotechnology
Therapeutic Areas
Hematology
Internal Medicine
Medical Affairs
Pharmacovigilance
Silvia Comis Summary
Silvia Comis, is currently a Head of Clinical Development and Regulatory Affairs at OSE Immunotherapeutics. Silvia Comis brings experience from previous roles at IQVIA and Novartis Oncology. Silvia Comis holds a Board Certified in Pharmacology @ Università degli Studi di Pavia. With a robust skill set that includes Clinical Research, Medicine, CTMS, Clinical Trials, Oncology and more. Silvia Comis has 3 emails on RocketReach.
Looking for a different Silvia Comis?
Find contact details for 700 million professionals.